PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 03, 2013


Shutterstock photo

PDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on December 03, 2013. A cash dividend payment of $0.15 per share is scheduled to be paid on December 12, 2013. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 12th quarter that PDLI has paid the same dividend. At the current stock price of $9.77, the dividend yield is 6.14%.

The previous trading day's last sale of PDLI was $9.77, representing a -0.91% decrease from the 52 week high of $9.86 and a 50.31% increase over the 52 week low of $6.50.

PDLI is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Amgen Inc. ( AMGN ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.68. Zacks Investment Research reports PDLI's forecasted earnings growth in 2013 as 21.09%, compared to an industry average of 8.4%.

For more information on the declaration, record and payment dates, visit the PDLI Dividend History page. Our Dividend Calendar has the full list of stocks that have an ex-dividend today.

Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:

  • WisdomTree Trust SmallCap Dividend Fund ( DES ).

The top-performing ETF of this group is DES with an increase of 10.14% over the last 100 days. It also has the highest percent weighting of PDLI at 0.82%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines Stocks
Referenced Stocks: AMGN , DES , GILD , PDLI

More from NASDAQ.com News


NASDAQ.com News

NASDAQ.com News

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com